Patents by Inventor Elbert Kaan

Elbert Kaan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Thermogenesis stimulating drugs
    Patent number: 6069147
    Abstract: The use of moxonidine an its physiologically compatible acid-addition salts for the treatment and/or prophylaxis of disorders of thermogenesis and for the stimulation of thermogenesis in persons with abnormally reduced energy turnover and/or persons with reduced thermogenesis during or following a weight loss diet is disclosed.
    Type: Grant
    Filed: April 6, 1999
    Date of Patent: May 30, 2000
    Assignee: Solvay Pharmaceuticals GmbH
    Inventors: Gareth Williams, Chen Bing, Elbert Kaan, Dieter Ziegler
  • Method of inhibiting hyperglycemia and pharmaceutical composition for use therein
    Patent number: 5972948
    Abstract: A method of using moxonidine or a physiologically acceptable acid addition salt thereof for the treatment and/or prophylaxis of glucose metabolism disorders such as insulin resistance and/or glucose intolerance, and pharmaceutical compositions for use therein.
    Type: Grant
    Filed: August 25, 1997
    Date of Patent: October 26, 1999
    Assignee: Solvay Pharmaceuticals GmbH
    Inventors: Elbert Kaan, Dieter Ziegler, Reinhard Brueckner
  • Method of inhibiting hyperglycemia and pharmaceutical composition for use therein
    Patent number: 5712283
    Abstract: A method of using moxonidine or a physiologically acceptable acid addition salt thereof for the treatment and/or prophylaxis of hyperglycaemia, and pharmaceutical compositions for use therein.
    Type: Grant
    Filed: June 20, 1995
    Date of Patent: January 27, 1998
    Assignee: Kali-Chemie Pharma GmbH
    Inventors: Elbert Kaan, Dieter Ziegler, Reinhard Brueckner